公司资料
Deciphera Pharmaceuticals 股价、新闻与催化剂
已退市
- 股票代码:
- DCPH
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for DCPH.
公司概览
业务概览
Deciphera Pharmaceuticals is an oncology company that has focused on kinase biology and targeted cancer therapies. The company’s commercial and pipeline efforts are rooted in precision oncology.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Deciphera sits in specialty oncology biotechnology.
商业模式特征
Its model depends on commercial execution, clinical development, and the ability to extend its targeted-therapy franchise.
生物医药行业定位
Deciphera is a focused oncology biotech whose valuation is driven by launch performance and pipeline milestones.
未来催化剂
- Deciphera's catalysts are QINLOCK, vimseltinib, and any remaining value-realization update that clarifies what is left to drive the story after the transaction backdrop. The next step matters because the stock is really about how much of the old standalone oncology story still has value.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。